IP Library Granted Patent US 9,737,469
Granted Patent B2
US 9,737,469 · App. 15/066,479 · Granted Aug 22, 2017

Methods for treating hair loss disorders

Inventors: Angela M. Christiano (Mahwah, NJ); Raphael Clynes (West Nyack, NY)
Assignee: The Trustees of Columbia University in the City of New York
A61K8/4953A61K8/41A61K8/64A61K31/137A61K31/277A61K31/407A61K31/437A61K31/506A61K31/519A61K31/52A61K31/529A61K31/5377A61K31/553A61K31/63A61K31/7052A61K31/713A61Q7/00A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,737,469
App. No.
15/066,479
Granted
Aug 22, 2017
Kind
B2
Abstract

The invention provides for methods for treating a hair loss disorder in a subject by administering a Janus Kinase/Signal Transducers and Activators of Transcription inhibitor.

Claims (13)

1. A method of treating a hair-loss disorder in a mammalian subject in need thereof, the method comprising administering to the subject an effective amount of an inhibitor of Janus Kinase (Jak)1, Jak2, or Jak3, wherein said inhibitor is LY3009104.

2. The method of claim 1 , wherein the hair-loss disorder comprises androgenetic alopecia, telogen effluvium, alopecia areata, telogen effluvium, tinea capitis, hypotrichosis, or hereditary hypotrichosis simplex.

3. The method of claim 2 , wherein the alopecia areata is alopecia totalis or alopecia universalis.

4. The method of claim 1 wherein the subject is a human.

5. The method of claim 4 wherein the hair loss-disorder is androgenetic alopecia.

6. The method of claim 1 wherein the hair loss-disorder is alopecia areata.

7. A method for inducing hair growth in a subject, the method comprising:

(a) administering to the subject an effective amount of a Jak1, Jak2, or Jak3 inhibitor, wherein said inhibitor is LY3009104,

thereby inducing hair growth in the subject.

8. The method of claim 7 , wherein the subject suffers from a hair-loss disorder, wherein the hair-loss disorder is selected from—androgenetic alopecia, telogen effluvium, alopecia areata, telogen effluvium, tinea capitis, hypotrichosis, and hereditary hypotrichosis simplex.

9. The method of claim 8 , wherein the alopecia areata is alopecia totalis or alopecia universalis.

10. The method of claim 8 wherein the hair loss-disorder is androgenetic alopecia.

11. The method of claim 8 wherein the hair loss-disorder is alopecia areata.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 29, 2016
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039204/0195 →
Continuity (8)
Continuation 14821623 · Aug 7, 2015
Continuation 13886252 · May 2, 2013
Continuation In Part PCTUS2011059029 · Nov 2, 2011
Continuation In Part PCTUS2013034688 · Mar 29, 2013
Provisional Application 61409509 · Nov 2, 2010
Provisional Application 61617225 · Mar 29, 2012
Provisional Application 61645499 · May 10, 2012
Related Publication 20160256461A1 · Sep 8, 2016